During the past decade, Wvu Department of Pediatrics conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wvu Department of Pediatrics" are "Abdominal Obesity" (1 trials), "Chronic Lung Disease" (1 trials), "Elevated Triglycerides" (1 trials), "Insulin Resistance" (1 trials) and "Systolic Hypertension" (1 trials). Many other conditions were trialed in "Wvu Department of Pediatrics" in a lesser frequency.

Most popular intervention types in "Wvu Department of Pediatrics" are "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Liquid Palivizumab" (1 trials), "Lyophilized Palivizumab" (1 trials), "energy restricted very-low carbohydrate diet" (1 trials), "low glycemic diet" (1 trials) and "standard ADA diet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wvu Department of Pediatrics" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Wvu Department of Pediatrics". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Wvu Department of Pediatrics, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wvu Department of Pediatrics, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".